JP Morgan Chase
CMMB

JP Morgan Chase’s Chemomab Therapeutics CMMB Stock Holding History

JP Morgan Chase’s Portfolio CMMB Stock Details CMMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-295
Closed -$1.37K – 7432
2025
Q2 		$1.37K Buy
+295
New +$1.46K ﹤0.01% 6586
2024
Q4 		– Sell
-275
Closed -$1.73K – 7433
2024
Q3 		$1.73K Buy
+275
New +$1.54K ﹤0.01% 6638
2024
Q2 		– Hold
0
– – – 7282
2024
Q1 		– Hold
0
– – – 7328
2022
Q2 		– Sell
-188
Closed -$4K – 6510
2022
Q1 		$4K Buy
+188
New +$3.71K ﹤0.01% 6342
2021
Q3 		– Sell
-13
Closed -$1K – 6509
2021
Q2 		$1K Buy
+13
New +$1.27K ﹤0.01% 6236

Other funds holding CMMB

SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return